Literature DB >> 25127465

Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.

Agnes Mihalyi1, Shirin Jamshidi1, Justinas Slikas1, Timothy D H Bugg2.   

Abstract

The National Cancer Institute (NCI) Diversity Set was screened for potential inhibitors of phospho-MurNAc-pentapeptide translocase MraY from Escherichia coli using a primary fluorescence enhancement assay, followed by a secondary radiochemical assay. One new MraY inhibitor was identified from this screen, a naphthylisoquinoline alkaloid michellamine B, which inhibited E. coli MraY (IC50 456μM) and Bacillus subtilis MraY (IC50 386μM), and which showed antimicrobial activity against B. subtilis (MIC 16μg/mL). Following an earlier report of halogenated fluoresceins identified from a combined MraY/MurG screen, three halogenated fluoresceins were tested as inhibitors of E. coli MraY and E. coli MurG, and phloxine B was identified as an inhibitor of E. coli MraY (IC50 32μM). Molecular docking of inhibitor structures against the structure of Aquifex aeolicus MraY indicates that phloxine B appears to bind to the Mg(2+) cofactor in the enzyme active site, while michellamine B binds to a hydrophobic groove formed between transmembrane helices 5 and 9.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial; Enzyme inhibition; Michellamine B; Peptidoglycan biosynthesis; Translocase MraY

Mesh:

Substances:

Year:  2014        PMID: 25127465     DOI: 10.1016/j.bmc.2014.07.035

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

Review 1.  Biologically active isoquinoline alkaloids covering 2014-2018.

Authors:  Xiao-Fei Shang; Cheng-Jie Yang; Susan L Morris-Natschke; Jun-Cai Li; Xiao-Dan Yin; Ying-Qian Liu; Xiao Guo; Jing-Wen Peng; Masuo Goto; Ji-Yu Zhang; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2020-07-29       Impact factor: 12.944

2.  Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway.

Authors:  Erik Henrich; Yi Ma; Ina Engels; Daniela Münch; Christian Otten; Tanja Schneider; Beate Henrichfreise; Hans-Georg Sahl; Volker Dötsch; Frank Bernhard
Journal:  J Biol Chem       Date:  2015-11-30       Impact factor: 5.157

3.  New Insight into the Catalytic Mechanism of Bacterial MraY from Enzyme Kinetics and Docking Studies.

Authors:  Yao Liu; João P G L M Rodrigues; Alexandre M J J Bonvin; Esther A Zaal; Celia R Berkers; Michal Heger; Katarzyna Gawarecka; Ewa Swiezewska; Eefjan Breukink; Maarten R Egmond
Journal:  J Biol Chem       Date:  2016-05-18       Impact factor: 5.157

4.  Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis.

Authors:  Anh T Tran; Emma E Watson; Venugopal Pujari; Trent Conroy; Luke J Dowman; Andrew M Giltrap; Angel Pang; Weng Ruh Wong; Roger G Linington; Sebabrata Mahapatra; Jessica Saunders; Susan A Charman; Nicholas P West; Timothy D H Bugg; Julie Tod; Christopher G Dowson; David I Roper; Dean C Crick; Warwick J Britton; Richard J Payne
Journal:  Nat Commun       Date:  2017-03-01       Impact factor: 14.919

5.  Bacillus subtilis MraY in detergent-free system of nanodiscs wrapped by styrene-maleic acid copolymers.

Authors:  Yao Liu; Elisabete C C M Moura; Jonas M Dörr; Stefan Scheidelaar; Michal Heger; Maarten R Egmond; J Antoinette Killian; Tamimount Mohammadi; Eefjan Breukink
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

6.  In Vitro Selective Antibacterial and Antiproliferative Effects of Ethanolic Extracts from Cambodian and Philippine Plants Used in Folk Medicine for Diarrhea Treatment.

Authors:  Tomas Kudera; Barbora Fiserova; Marie Korytakova; Ivo Doskocil; Hana Salmonova; Edgardo E Tulin; Samnang Nguon; Marlito M Bande; Ladislav Kokoska
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

Review 7.  Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: The discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics.

Authors:  Ken-Ichi Kimura
Journal:  J Antibiot (Tokyo)       Date:  2019-10-04       Impact factor: 2.649

Review 8.  The Membrane Steps of Bacterial Cell Wall Synthesis as Antibiotic Targets.

Authors:  Yao Liu; Eefjan Breukink
Journal:  Antibiotics (Basel)       Date:  2016-08-26

Review 9.  Structural Insights into Protein-Protein Interactions Involved in Bacterial Cell Wall Biogenesis.

Authors:  Federica Laddomada; Mayara M Miyachiro; Andréa Dessen
Journal:  Antibiotics (Basel)       Date:  2016-04-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.